A novel iris transillumination grading scale allowing flexible assessment with quantitative image analysis and visual matching

ABSTRACT Purpose: To develop a sensitive scale of iris transillumination suitable for clinical and research use, with the capability of either quantitative analysis or visual matching of images. Methods: Iris transillumination photographic images were used from 70 study subjects with ocular or oculocutaneous albinism. Subjects represented a broad range of ocular pigmentation. A subset of images was subjected to image analysis and ranking by both expert and nonexpert reviewers. Quantitative ordering of images was compared with ordering by visual inspection. Images were binned to establish an 8-point scale. Ranking consistency was evaluated using the Kendall rank correlation coefficient (Kendall’s tau). Visual ranking results were assessed using Kendall’s coefficient of concordance (Kendall’s W) analysis. Results: There was a high degree of correlation among the image analysis, expert-based and non-expert-based image rankings. Pairwise comparisons of the quantitative ranking with each reviewer generated an average Kendall’s tau of 0.83 ± 0.04 (SD). Inter-rater correlation was also high with Kendall’s W of 0.96, 0.95, and 0.95 for nonexpert, expert, and all reviewers, respectively. Conclusions: The current standard for assessing iris transillumination is expert assessment of clinical exam findings. We adapted an image-analysis technique to generate quantitative transillumination values. Quantitative ranking was shown to be highly similar to a ranking produced by both expert and nonexpert reviewers. This finding suggests that the image characteristics used to quantify iris transillumination do not require expert interpretation. Inter-rater rankings were also highly similar, suggesting that varied methods of transillumination ranking are robust in terms of producing reproducible results.

[1]  C. Summers,et al.  Hermansky-Pudlak syndrome. Ophthalmic findings. , 1988 .

[2]  E. Kuehl,et al.  Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism. , 2000, Ophthalmology.

[3]  Karen Brondum-Nielsen,et al.  Oculocutaneous albinism , 2007, Orphanet journal of rare diseases.

[4]  A. Ballabio,et al.  Amelioration of both functional and morphological abnormalities in the retina of a mouse model of ocular albinism following AAV-mediated gene transfer. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  C. Summers.  Albinism: Classification, Clinical Characteristics, and Recent Findings , 2009, Optometry and vision science : official publication of the American Academy of Optometry.

[6]  M. Brilliant,et al.  Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism. , 2011, The Journal of clinical investigation.

[7]  C. Decatur,et al.  L-DOPA Is an Endogenous Ligand for OA1 , 2008, PLoS biology.

[8]  Z. Ahmed,et al.  OCA5, a novel locus for non‐syndromic oculocutaneous albinism, maps to chromosome 4q24 , 2013, Clinical genetics.

[9]  Michael G. Anderson,et al.  Elevated Oxidative Membrane Damage Associated with Genetic Modifiers of Lyst-Mutant Phenotypes , 2010, PLoS genetics.

[10]  E. Surace,et al.  AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1). , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  R. Kelsh,et al.  Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. , 2013, American journal of human genetics.

[12]  Seong-Joon Kim,et al.  Correlation of visual acuity with foveal hypoplasia grading by optical coherence tomography in albinism. , 2007, Ophthalmology.

[13]  A. Wei,et al.  Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. , 2013, The Journal of investigative dermatology.